-- Bakrieland, Kimia Farma, Semen Gresik: Indonesia Equity Preview
-- B y   B e r n i   M o e s t a f a
-- 2012-03-13T01:24:20Z
-- http://www.bloomberg.com/news/2012-03-13/bakrieland-kimia-farma-semen-gresik-indonesia-equity-preview.html
Shares of the following companies
may have  unusual  moves in  Indonesian trading . Stock symbols are
in parentheses, and share prices are as of the previous close.  The  Jakarta Composite index  fell 0.1 percent to 3,987.35.  PT Astra International (ASII)  : Honda Motor Corp. will
invest 30 billion yen ($365 million) for a plant in  Indonesia  to
increase motorcycle production capacity by 25 percent by the
fall of 2013, the Nikkei newspaper reported, without saying
where it got its information. Astra, Indonesia’s biggest
automotive retailer that sells Honda motorcycles, slid 0.6
percent to 69,800 rupiah.  PT Bakrieland Development (ELTY)  : The property developer
plans to spend 870 billion rupiah ($95 million) to build hotels
and resorts in a number of cities until 2015, Investor Daily
Indonesia reported, citing Norman Daulay, a managing director at
the company’s Hotels & Resorts business unit. The company’s
biggest investment of 750 billion rupiah will be spent on
developing the Nirwana Bali Resort, the report said. Bakrieland
was unchanged at 129 rupiah.  PT Kimia Farma (KAEF)  : The state-owned drug maker plans
to invest 1.2 trillion rupiah over a two-year period to double
capsule and tablet production capacity and to add new products,
Kontan reported, citing President Director Muhammad Sjamsul Arifin. Kimia Farma was unchanged at 440 rupiah.  PT Semen Gresik (SMGR)  : Indonesia’s biggest cement
producer plans to a build a plant in Myanmar this year with an
output capacity of 1.5 million tons to 2.5 million tons and at a
cost of $300 million to $500 million, Investor Daily Indonesia
reported, citing Finance Director Ahyanizzaman. Gresik was
unchanged at 11,300 rupiah.  To contact the reporter on this story:
Berni Moestafa in Jakarta at 
 bmoestafa@bloomberg.net   To contact the editor responsible for this story:
Darren Boey at   dboey@bloomberg.net  